Editas Medicine, Inc.
EDIT
$1.28
$0.010.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -54.74% | -7.94% | 6.00% | 24.12% | 30.49% |
| Total Depreciation and Amortization | -4.21% | -4.55% | -7.28% | -6.23% | -4.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.91% | -15.00% | -24.50% | -23.58% | -42.00% |
| Change in Net Operating Assets | 316.44% | -59.70% | -46.90% | -111.80% | -119.50% |
| Cash from Operations | -59.09% | -19.41% | 0.07% | 10.74% | 25.47% |
| Capital Expenditure | -87.03% | -137.69% | -56.68% | -28.03% | -14.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17,204.86% | 326.09% | -86.19% | -131.89% | -99.16% |
| Cash from Investing | 4,445.91% | 306.20% | -92.62% | -139.21% | -103.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.34% | -99.13% | -99.13% | 10,991.09% | 9,093.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.54% | -99.13% | -99.13% | 10,991.09% | 9,093.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.15% | 110.37% | -404.14% | 26.96% | 71.18% |